Competition Law and Policy in the Japanese Pharmaceutical Sector
This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intell...
Shranjeno v:
| Drugi avtorji: | , , |
|---|---|
| Format: | Livre numérique |
| Jezik: | Anglais |
| Izdano: |
Singapore :
Springer Nature Singapore
[20..].
Cham : Springer Nature |
| Serija: | Kobe University Monograph Series in Social Science Research
|
| Online dostop: | Accès sur la plateforme Springer Accès sur la plateforme ISTEX Accès Université d'Orléans |
| Sporočilo: |
Springer e-books droit et criminologie (Licence nationale) |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Competition Law and Policy in the Japanese Pharmaceutical Sector, Texte imprimé, 9789811678134 • Competition Law and Policy in the Japanese Pharmaceutical Sector, Texte imprimé, 9789811678158 • Competition Law and Policy in the Japanese Pharmaceutical Sector, Texte imprimé, 9789811678165 |
Kazalo:
- Preface
- PART I HEALTHCARE AND PHARMACEUTICALS: INNOVATION AND REGULATION IN JAPAN
- Regulation and Competition in the Pharmaceutical Industry in Japan
- Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population
- Drug Regulation in Japan
- Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan
- Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies Gift-giving Practices
- PART II THE JAPANESE ANTIMONOPOLY ACT AND ITS RELATION TO THE PHARMACEUTICAL INDUSTRY
- Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan
- Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act
- Merger Regulations in the Japanese Pharmaceutical Industry
- Pay-for-delay Agreements in Japan
- No Challenge Clauses in the Pharmaceutical Industry in Japan
- Will Authorised Biologics deter Biosimilars? -Utilising JFTC s expertise in drug pricing
- PART III AN ECONOMIC ANALYSIS OF THE PHARMACEUTICAL INDUSTRY AND TRADE PRACTICES IN JAPAN
- The Pharmaceutical Industry in Japan: A History of Its Development
- Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.